Healthy men help scientists measure drug absorption in Early-Stage trial
NCT ID NCT05707403
First seen Dec 08, 2025 · Last updated May 27, 2026 · Updated 27 times
Summary
This completed Phase 1 study involved 8 healthy men to find out how much of the drug BI 1015550 gets into the blood after taking it by mouth. Participants received a single oral dose plus a tiny radioactive tracer dose by IV. The goal was purely to understand the drug's behavior, not to treat any disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
ICON
Groningen, 9728 NZ, Netherlands
Conditions
Explore the condition pages connected to this study.